Patient advocacy organizations look to partner with pharma companies

June 14, 2022 -- Patient advocacy organizations are looking to partner with pharmaceutical companies, offering resources and expertise to maximize the impact and efficiency of their therapeutic R&D programs. It’s a message that these groups want to drive home to pharma at the 2022 Biotechnology Innovation Organization (BIO) International Convention in San Diego.

"There is an incredibly unique vantage point that nonprofits and advocacy organizations can serve," Danielle Kerkovich, PhD, director of research development and partnerships for the International Fibrodysplasia Ossificans Progressiva Association (IFOPA), told "We do have resources that are incredibly valuable to de-risking some of these programs so that pharmaceutical companies can ultimately be successful."

Kerkovich was a panelist for the June 14 panel at BIO 2022 titled, "Partnering for Progress: Collaborating With Patient Organizations To Advance Therapy Development and Maximize Patient Benefit."

IFOPA maintains the world's only patient registry for patients with Fibrodysplasia Ossificans Progressiva (FOP), a rare genetic disorder that causes soft tissues to transform permanently into bone. Currently, six pharma companies have access to the real-world data in the patient registry.

"It's also important that we provide this go-between between drug developers and academic institutions that are working on advancing programs and the patients, to make sure that the two sides are considering one another's perspectives," said Michelle Davis, executive director of IFOPA. "One of the activities that we participate in is making the [patient] community aware about the drug development process and about the process of clinical studies and trials."

Watch the video below to learn more.

Copyright © 2022

Create an Account

Already have an account? Sign in Here

To access all ScienceBoard content create a free account now:

Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for

Email Preferences

Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.